Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD

Recruiting N/A Interventional Study
Coronary Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
2,400 (estimated)
Sponsor
Seung-Whan Lee, M.D., Ph.D. · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is to compare clinical outcomes between quantitative coronary angiography-guided anatomic complete revascularization and fractional flow reserve-guided physiologic complete revascularization in patients with significant coronary artery disease undergoing percutaneous coronary intervention with drug eluting stent

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men or women between the ages of 19and older * Typical chest pain or objective evidence of myocardial ischemia suitable for PCI Significant lesions with a diameter stenosis of 50-90% in major epicardial coronary arteries ≥ 2.25 mm in diameter by visual estimation. * The patien…
Contacts

Jiwon Baek, RN

82230107267

cvcrc22@amc.seoul.kr

CONTACT

Seung-Whan Lee, Investigator

82230103170

seungwlee@amc.seoul.kr

CONTACT